Regarding research on CPT2, Fujiwara et al. discovered that, in obesity- and nonalcoholic steatohepatitis-driven hepatocellular carcinoma, the downregulation of CPT2 accelerated tumor progression [22]. The gene discussed is CPT2; the disease is obesity disorder.